Abstract:Due to the absence of safe and effective carriers for in vivo delivery, the applications of small interference RNA (siRNA) in clinic for therapeutic purposes have been limited. In this study, a biodegradable amphiphilic tri-block copolymer (mPEG(2000)-PLA(3000)-b-R(15)) composed of monomethoxy poly(ethylene glycol), poly(d,l-lactide) and polyarginine was synthesized and further self-assembled to cationic polymeric nanomicelles for in vivo siRNA delivery, with an average diameter of 54.30 ± 3.48 nm and a zeta potential of approximately 34.8 ± 1.77 mV. The chemical structures of the copolymers were well characterized by (1)H NMR spectroscopy and FT-IR spectra. In vitro cytotoxicity and hemolysis assays demonstrated that the polymeric nanomicelles showed greater cell viability and haemocompatibility than those of polyethyleneimine (PEI) or R(15) peptide. In vitro experiments demonstrated that EGFR targeted siRNA formulated in micelleplexes exhibited approximately 65% inhibition of EGFR expression on MCF-7 cells in a sequence-specific manner, which was comparable to Lipofectamine™ 2000. The results of intravenous administration showed Micelleplex/EGFR-siRNA significantly inhibited tumor growth in nude mice xenografted MCF-7 tumors, with a remarkable inhibition of EGFR expression. Furthermore, no positive activation of the innate immune responses and no significant body weight loss was observed during treatment suggested that this polymeric micelle delivery system is non-toxic. In conclusion, the present nanomicelles based on cationic mPEG(2000)-PLA(3000)-b-R(15) copolymer would be a safe and efficient nanocarrier for in vivo delivery of therapeutic siRNA.

Lipid-Modified Aminoglycoside Derivatives for in Vivo Sirna Delivery

Drug Delivery: Lipid‐Modified Aminoglycoside Derivatives for in Vivo Sirna Delivery (adv. Mater. 33/2013)

Lipopeptide Nanoparticles for Potent and Selective Sirna Delivery in Rodents and Nonhuman Primates.

A Novel Gemini-Like Cationic Lipid For The Efficient Delivery Of Sirna

Novel Lipoidal Amine-Based Nanocarrier Formulations for Sirna Delivery

Optimized Fluorodendrimer-Incorporated Hybrid Lipid-Polymer Nanoparticles for Efficient Sirna Delivery.

Lipid-Based Nanoparticles in the Systemic Delivery of Sirna

Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation.

Delivery of Sirna Using Lipid Nanoparticles Modified with Cell Penetrating Peptide.

Ionizable Amphiphilic Dendrimer-Based Nanomaterials with Alkyl-Chain-Substituted Amines for Tunable Sirna Delivery to the Liver Endothelium in Vivo

Hybrid Lipid–polymer Nanoparticles for Sustained Sirna Delivery and Gene Silencing

Multifunctional, Self-Assembling Anionic Peptide-Lipid Nanocomplexes for Targeted Sirna Delivery.

Single-walled Carbon Nanotubes Noncovalently Functionalized with Lipid Modified Polyethylenimine for Sirna Delivery in Vitro and in Vivo.

Optimization in Chemical Modification of Single-Stranded Sirna Encapsulated by Neutral Cytidinyl/Cationic Lipids

Lipid-like Nanomaterials for Simultaneous Gene Expression and Silencing in Vivo.

The Development of Tertiary Amine Cationic Lipids for Safe and Efficient Sirna Delivery

Quantum Dot-Amphipol Nanocomplex for Intracellular Delivery and Real-Time Imaging of Sirna

Microfluidic-Based Cationic Cholesterol Lipid siRNA Delivery Nanosystem: Highly Efficient In Vitro Gene Silencing and the Intracellular Behavior

Self-assembly Nanomicelles Based on Cationic Mpeg-Pla-b-polyarginine(r15) Triblock Copolymer for Sirna Delivery.

Efficient Systemic Delivery Of Sirna By Using High-Density Lipoprotein-Mimicking Peptide Lipid Nanoparticles

SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles